SightGlass Vision has launched a new global professional education campaign, “Control the Contrast,” aimed at increasing awareness of contrast management as an emerging approach to myopia control.
Announced in April 2026, the initiative targets eye care professionals and focuses on the company’s Diffusion Optics Technology (DOT™) spectacle lenses, which are designed to modulate contrast on the retina. According to clinical data cited by the company, DOT lenses have been shown to slow average myopia progression by up to 75 percent over 12 months in children.
The campaign comes amid growing concern over rising rates of childhood myopia, linked in part to increased time spent indoors in visually uniform, artificial environments. SightGlass argues that these environments may contribute to abnormal eye growth, and that modifying retinal contrast could help mitigate this effect.
DOT lenses incorporate thousands of light-scattering elements intended to mimic more natural visual conditions. The technology has already been introduced in several markets, including the UK, Canada, China, Israel, and Spain, with more than 1.5 million children fitted to date. The lenses are not currently available in the United States.
Through a dedicated online platform, the “Control the Contrast” campaign provides educational resources on the role of environmental contrast in eye development, alongside materials to support clinical adoption.
Andrew Sedgwick, CEO of SightGlass Vision, said the goal is to encourage earlier intervention by expanding clinician understanding of available treatment options. “More children are developing myopia at a younger age, making it even more crucial for eye care professionals to be aware of all the options at their disposal for early intervention,” Sedgwick said in a recent press release. “By building awareness and understanding of the science behind contrast management and DOT lenses’ unique approach to controlling myopia, we hope more eye care professionals will take action.”
The initiative reflects a broader industry shift toward non-invasive, spectacle-based strategies for managing myopia progression in pediatric populations.
Source: SightGlass Vision.
